Skip to main content
Livermore
Livermore
ZHEN

Van Eck Associates Corp

SEC CIK
0000869178
Latest filing
Aug 14, 2026

WST holding history

West Pharmaceutical Services Inc in every 13F filed by Van Eck Associates Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WST overviewAll 13F holders of WSTFull Q2 2026 holdings

Shares (Q2 2026)
604,754
Value
$217.1M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of WST by Van Eck Associates Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026604,754$217.1M0.1%−108,825−15.3%ReducedHolders
Q1 2026713,579$178.9M0.1%−2,508−0.4%ReducedHolders
Q4 2025716,087$197.0M0.2%−708,792−49.7%ReducedHolders
Q3 20251,424,879$373.8M0.3%−61,308−4.1%ReducedHolders
Q2 20251,486,187$325.2M0.4%+38,339+2.6%AddedHolders
Q1 20251,447,848$324.1M0.4%+758,355+110.0%AddedHolders
Q4 2024689,493$225.9M0.3%+676,167+5,074.0%AddedHolders
Q3 202413,326$3.82M<0.1%−722−5.1%ReducedHolders
Q2 202414,048$4.63M<0.1%+436+3.2%AddedHolders
Q1 202413,612$5.39M<0.1%+2,873+26.8%AddedHolders
Q4 202310,739$3.78M<0.1%+226+2.1%AddedHolders
Q3 202310,513$3.94M<0.1%−2,405−18.6%ReducedHolders
Q2 202312,918$4.94M<0.1%−221−1.7%ReducedHolders
Q1 202313,139$4.55M<0.1%+330+2.6%AddedHolders
Q4 202212,809$3.02M<0.1%−237−1.8%ReducedHolders
Q3 202213,046$3.21M<0.1%+950+7.9%AddedHolders
Q2 202212,096$3.66M<0.1%−144−1.2%ReducedHolders
Q1 202212,240$5.03M<0.1%+1,360+12.5%AddedHolders
Q4 202110,880$5.10M<0.1%+1,384+14.6%AddedHolders
Q3 20219,496$4.03M<0.1%+417+4.6%AddedHolders
Q2 20219,079$3.26M<0.1%+1,213+15.4%AddedHolders
Q1 20217,866$2.22M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.